Stephen Luo is a Partner of Jingtian & Gongcheng LLP. He respectively received a Master of Law from Renmin University of China and a Bachelor of Law from Hong Kong University.

Mr. Stephen Luo worked at Shearman & Sterling before joining our firm.

Mr. Stephen Luo passed the National Legal Qualification Examination of the PRC.

Education:

LLM, Renmin University of China

PCLL, University of Hong Kong

LLB (Simon K.Y. Lee Medal in Law), University of Hong Kong 

Working experience:

Jingtian & Gongcheng LLP           Partner
Shearman & Sterling LLP        Lawyer

Admission:

Passed the National Legal Qualification Examination of the PRC

Representing Citigroup Global Markets Asia Limited, Citigroup Global Markets Limited, CITIC CLSA Capital Markets Limited and CLSA Limited, as joint sponsors and joint global coordinators, in the H share global offering and initial public offering of Wenzhou Kangning Hospital Co., Ltd. on the Main Board of HKEx

Representing BOCI Asia Limited and Citigroup Global Markets Asia Limited, as joint sponsors, in the global offering and initial public offering of VPower Group International Holdings Limited on the Main Board of HKEx

Representing Tianli Education International Holdings Limited in its global offering and initial public offering on the Main Board of HKEx

Representing the controlling shareholder of Future Land Development Holdings Limited in its US$661 million privatization by way of scheme of arrangement

Representing China Resources Phoenix Healthcare Holdings Company Limited (formerly known as Phoenix Healthcare Group Co. Ltd) in its US$480 million acquisition of hospital assets from China Resources Healthcare Group Limited and US$160 million acquisition of hospital assets from CITIC Medical & Health Group Co., Ltd.

Representing Inner Mongolia Yili Industrial Group Co., Ltd in its US$680 million acquisition of Shengmu Organic Milk Limited

Representing China Culiangwang Beverages Holdings Limited in its US$400 million sale of beverage business to Coca-Cola Beverages (Shanghai) Company Limited

Representing Rothschild (Hong Kong) Limited, as sole sponsor, in Alibaba Health Information Technology Limited’s reverse takeover of Tmall’s online pharmacy store business with a new listing on the HKEx

Representing Future Land Development Holdings Limited in its US$200 million to-up placing and issuance of HK$2,346 million 2.25% convertible bonds due 2019